KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Return on Sales (2016 - 2025)

AbbVie (ABBV) has disclosed Return on Sales for 14 consecutive years, with 0.11% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales rose 11.0% to 0.11% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.07%, a 1.0% decrease, with the full-year FY2025 number at 0.07%, down 1.0% from a year prior.
  • Return on Sales was 0.11% for Q4 2025 at AbbVie, up from 0.01% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.33% in Q1 2022 to a low of 0.01% in Q1 2023.
  • A 5-year average of 0.13% and a median of 0.11% in 2024 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: grew 27bps in 2021, then plummeted -34bps in 2023.
  • AbbVie's Return on Sales stood at 0.27% in 2021, then plummeted by -40bps to 0.16% in 2022, then tumbled by -50bps to 0.08% in 2023, then tumbled by -102bps to 0.0% in 2024, then surged by 7271bps to 0.11% in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Return on Sales are 0.11% (Q4 2025), 0.01% (Q3 2025), and 0.06% (Q2 2025).